TNF and amyotrophic lateral sclerosis: First, we found a robust upregulation of proinflammatory cytokines, interleukins, tumor necrosis factor, and GFAP, in the CSF of SOD1‐ALS patients on tofersen for 12 months compared with baseline (Fig. S13).